RAS blockade: Nephroprotection by dual RAS blockade—a welcome back

Nature Reviews Nephrology 11, 507 (2015). doi:10.1038/nrneph.2015.132 Authors: Piero Ruggenenti & Giuseppe Remuzzi A new meta-analysis shows that dual blockade of the renin–angiotensin system is the most effective approach to prevent end-stage renal disease in patients with diabetes and kidney disease. Combination therapy should therefore be reconsidered as the most powerful tool for nephroprotection, provided that treatment is individually tailored by careful dose-titration.

http://feeds.nature.com/~r/nrneph/rss/current/~3/u45xjJ_oHeU/nrneph.2015.132

Source: Nature Reviews Nephrology - August 4, 2015 Category: Urology & Nephrology Authors: Piero RuggenentiGiuseppe Remuzzi Tags: News and Views Source Type: research

More News: Diabetes | Endocrinology | Urology & Nephrology